FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:1079-1080 April 9, 1998 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by H. Hunt Batjer, with Louis R. Caplan, Lars Friberg, Ralph G. Greenlee, Jr., Thomas A. Kopitnik, Jr., and William L. Young. 1276 pp., illustrated. Philadelphia, Lippincott–Raven, 1997. $275. ISBN 0-397-51661-4.

Recent years have seen a surge in publications of all sorts in the field of cerebrovascular disease: research papers, reviews, and textbooks. Driving this activity is the burst of new information about the mechanisms underlying ischemic or hemorrhagic brain damage and the consequent rapid development of new diagnostic and therapeutic modalities. In a manner comparable to the revolution in the treatment of acute myocardial infarction that occurred in the 1980s, the clinical approach to stroke is now evolving from passive acceptance to active management, which encompasses both prophylactic risk reduction and acute care interventions such as thrombolysis and neuroprotection.

This . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.